ArticleOxidative medicine and cellular longevity2021

Downregulation of CYP39A1 Serves as a Novel Biomarker in Hepatocellular Carcinoma with Worse Clinical Outcome.

Dan Li et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.